A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
The Evolution of Spinal Stability: Medtronic’s Infuse™ Bone Graft Receives FDA Approval for TLIF on September 28, 2026 Posted by
The Intersection of GLP-1 Medications and Sleep Apnea: A Comprehensive Guide to Treatment and Coverage on September 28, 2026 Posted by
Advancing the Frontier of Pain Management: Dr. Ball Achieves Medidata Certification on September 28, 2026 Posted by
A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
Posted in Medical Innovations Novartis Bets Big on Brain-Delivery Tech in $125M Sironax Acquisition on September 16, 2026
Posted in Digital Health Tools Novartis Bets $125M on Sironax Brain-Delivery Tech Amid Neuroscience Pipeline Turbulence on September 16, 2026
Posted in Digital Health Tools Pharma Market Volatility: Novartis Faces Investor Skepticism as Biosimilar Pipeline Stalls on September 11, 2026
Posted in Digital Health Tools Pharma Industry Turbulence: Novartis Under Fire and the Evolution of U.S. Drug Pricing on September 11, 2026
Posted in Medical Innovations A Difficult Week for Big Pharma: Novartis and Novo Nordisk Face High-Stakes R&D Setbacks on September 9, 2026
Posted in Medical Innovations Novartis Faces Investor Backlash After $12B Bet on Del-Desiran Hits Clinical Wall on September 8, 2026
Posted in Medical Innovations A Major Setback in Cardiology: Novartis’ Pelacarsen Fails Pivotal Phase 3 Trial on September 4, 2026
Posted in Medical Innovations Novartis’ Remibrutinib: A Potential Paradigm Shift in the High-Stakes Race for BTK Inhibition on September 1, 2026
Posted in Medical Innovations Setback in the "Immune Reset" Frontier: Novartis and Bristol Myers Pause CAR-T Autoimmune Trials on August 31, 2026
Posted in Medical Innovations Novartis’ Pacibekitug Shows Promise in Midstage Cardiovascular Trial: A New Frontier in Inflammation Management on August 29, 2026
